Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

BACKGROUND: Although serotonin reuptake inhibitors are effective in the treatment of OCD, many patients fail to respond to these agents. Growing evidence from open-label and placebo-controlled trials suggests a role for augmentation of SRIs with atypical antipsychotics in OCD. Quetiapine is generall...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Carey, Paul D, Vythilingum, Bavanisha, Seedat, Soraya, Muller, Jacqueline E, van Ameringen, Michael, Stein, Dan J
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2005
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC547907/
https://ncbi.nlm.nih.gov/pubmed/15667657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-244X-5-5
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak